Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene
- PMID: 16364913
- DOI: 10.1016/j.molcel.2005.10.026
Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene
Abstract
Ron, the tyrosine kinase receptor for the Macrophage-stimulating protein, is involved in cell dissociation, motility, and matrix invasion. DeltaRon, a constitutively active isoform that confers increased motility to expressing cells, is generated through the skipping of exon 11. We show that abnormal accumulation of DeltaRon mRNA occurs in breast and colon tumors. Skipping of exon 11 is controlled by a silencer and an enhancer of splicing located in the constitutive exon 12. The strength of the enhancer parallels the relative abundance of DeltaRon mRNA and depends on a sequence directly bound by splicing factor SF2/ASF. Overexpression and RNAi experiments demonstrate that SF2/ASF, by controlling the production of DeltaRon, activates epithelial to mesenchymal transition leading to cell locomotion. The effect of SF2/ASF overexpression is reverted by specific knockdown of DeltaRon mRNA. This demonstrates a direct link between SF2/ASF-regulated splicing and cell motility, an activity important for embryogenesis, tissue formation, and tumor metastasis.
Similar articles
-
Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.EMBO J. 1996 Oct 1;15(19):5415-27. EMBO J. 1996. PMID: 8895585 Free PMC article.
-
Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.Aging Cell. 2011 Oct;10(5):896-907. doi: 10.1111/j.1474-9726.2011.00727.x. Epub 2011 Jul 19. Aging Cell. 2011. PMID: 21668763
-
Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene.J Cell Biol. 2010 Oct 4;191(1):87-99. doi: 10.1083/jcb.201001073. Epub 2010 Sep 27. J Cell Biol. 2010. PMID: 20876280 Free PMC article.
-
Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives.RNA Biol. 2010 Jul-Aug;7(4):495-503. doi: 10.4161/rna.7.4.12744. Epub 2010 Jul 1. RNA Biol. 2010. PMID: 20864806
-
HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition.Nucleic Acids Res. 2013 Oct;41(18):8665-79. doi: 10.1093/nar/gkt579. Epub 2013 Jul 17. Nucleic Acids Res. 2013. PMID: 23863836 Free PMC article.
Cited by
-
Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.PLoS One. 2012;7(10):e46539. doi: 10.1371/journal.pone.0046539. Epub 2012 Oct 10. PLoS One. 2012. PMID: 23071587 Free PMC article.
-
Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics.Genes (Basel). 2023 Oct 26;14(11):2001. doi: 10.3390/genes14112001. Genes (Basel). 2023. PMID: 38002944 Free PMC article. Review.
-
Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition.J Biol Chem. 2012 Oct 19;287(43):36435-42. doi: 10.1074/jbc.M112.397125. Epub 2012 Sep 7. J Biol Chem. 2012. PMID: 22961986 Free PMC article.
-
Chronic Replication Problems Impact Cell Morphology and Adhesion of DNA Ligase I Defective Cells.PLoS One. 2015 Jul 7;10(7):e0130561. doi: 10.1371/journal.pone.0130561. eCollection 2015. PLoS One. 2015. PMID: 26151554 Free PMC article.
-
RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues.Mol Cell Biol. 2013 Jan;33(2):396-405. doi: 10.1128/MCB.01174-12. Epub 2012 Nov 12. Mol Cell Biol. 2013. PMID: 23149937 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
